Familial Investigations of Childhood Cancer Predisposition
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to AML
Related studies linked through entity extraction aliases.
Efficacy and Safety of Chidamide in CBF Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Efficacy of Decitabine in Clearance of MRD
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Pre-emptive Immunomodulation After Allogeneic Stem Cell Transplantation in AML
- Status
- UNKNOWN
- Phase
- N/A
Chidamide Plus DCAG for Relapsed/Refractory AML
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Decitabine Based Chemotherapy Followed by Haploidentical Lymphocyte Infusion for Elderly Patients With AML
- Status
- COMPLETED
- Phase
- PHASE2
Photochemotherapy and Graft-versus-leukemia in Acute-leukemia
- Status
- COMPLETED
- Phase
- N/A
Epidemiologic Registry PETHEMA LMA 2015
- Status
- UNKNOWN
- Phase
- N/A
VILMA: Therapeutic Results in Acute Mieloblastic Leukemia in Patients Older Than 60 Years
- Status
- COMPLETED
- Phase
- N/A
Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Participants With Acute Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2